Navigation Links
Verenium Reports Financial Results For The Second Quarter And Six Months Ended June 30, 2012
Date:8/6/2012

SAN DIEGO, Aug. 6, 2012 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today reported operating highlights and financial results for the second quarter and six months ended June 30, 2012.

"The first half of the year proved to be an important turning point for Verenium," said James Levine, President & Chief Executive Officer at Verenium.  "With the recent move into our new facility completed and our debt repaid, we are focused on growing our business through the sales of our current marketed products, developing our product pipeline, and establishing future collaborations and partnerships."

Company HighlightsSince the beginning of 2012, the Company has made progress on both operational and financial fronts.  Recent accomplishments include:

  • Completed a strategic transaction with DSM Food Specialties, B.V. ("DSM"), including the sale of the Company's oilseed processing business, for total consideration of $37 million;
  • Repurchased $34.9 million in convertible notes outstanding, retiring all of the Company's remaining debt;
  • Announced that the Company's next-generation enzyme breaker was authorized for use in hydraulic fracturing by the Environmental Protection Agency (EPA);
  • Completed moving into the Company's new office and state-of-the-art laboratory and pilot plant facility in San Diego, California; and
  • Ended the second quarter with unrestricted cash of $14.4 million and $5.7 million in restricted cash.

    • Financial ResultsIn the commentary below, the operating results of the Company's oilseed processing business, sold to DSM in March 2012, for prior periods are included in continuing operations.

    Revenues

    Revenues for the periods ended June 30, 2012 and 2
    '/>"/>

    SOURCE Verenium Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10

    Related biology technology :

    1. Verenium Corporation To Announce Second Quarter 2012 Financial Results
    2. Verenium Announces EPA Authorization To Market Its Next-Generation Enzyme Breaker For Hydraulic Fracturing
    3. Verenium Corporation And Alexandria Real Estate Equities, Inc. Celebrate The Grand Opening Of A New State-of-the-art Biotechnology Facility
    4. Verenium Corporation Named One Of The 2012 Best Places to Work in San Diego
    5. Verenium Corporation To Announce First Quarter 2012 Financial Results
    6. Verenium Corporation to Announce Fourth Quarter and Year-End 2011 Financial Results
    7. First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration
    8. Verenium to Present at Baird Clean Technology Conference
    9. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
    10. Cadence Pharmaceuticals Reports Second Quarter 2012 Financial Results
    11. Discovery Labs Reports Second Quarter 2012 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/24/2013)... May 24, 2013 This market ... on kinase profiling carried out in May 2013. ... the breakdown of the responses for each question, ... (2015). It also highlights some interesting differences, particularly ... Two bottom-up models were developed to estimate the ...
    (Date:5/24/2013)... 24, 2013 Vestiage, Inc. (stock ... focused on science-based research and development, sales and ... and nutraceuticals, announced today that it is awarding ... the sale of Reluma Skin Illuminating Facial Care. ... application by sending an email to info(at)vestiageinc(dot)com and ...
    (Date:5/23/2013)... baby stopped breathing, his collapsed bronchus blocking the crucial ... Gionfriddo watched helplessly, just praying that somehow the dire ... he had a good chance of not leaving the ... son, Kaiba. "At that point, we were desperate. Anything ... with it." , They found hope at the University ...
    (Date:5/23/2013)... Can economic incentives such as gift cards, ... the public to increase their donations of blood? , ... Business School Assistant Professor Mario Macis says the ... body of recent research that supports their argument, the ... of Science that the World Health Organization and national ...
    Breaking Biology Technology:Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 2Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 3Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5Baby's life saved with groundbreaking 3-D printed device that restored his breathing 2Baby's life saved with groundbreaking 3-D printed device that restored his breathing 3Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3
    ... China, Feb. 7 /Xinhua-PRNewswire-FirstCall/ -- Tianyin,Pharmaceutical, Inc., (OTC ... traditional Chinese medicine (TCM) based in Chengdu,China, today ... the Board of,Directors, will host a conference call ... results., The conference call will take place ...
    ... 7 Dilon Technologies, makers of,a gamma imaging system ... Moussa to the position of President and Chief Executive,Officer., ... the medical device industry,having held a number of senior ... a health care corporation he ran as,CEO for a ...
    ... 7 MedImmune today announced,that it has strengthened ... affairs with three key promotions and has also ... Kiener, D. Phil. has been appointed,to executive vice ... organization development, HR; and Eileen Valenta to vice ...
    Cached Biology Technology:Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST 2Newly Appointed Dilon Technologies President & CEO Robert G. Moussa Sees BSGI as ' ... Major Weapon in the Battle Against Cancer' 2MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio 2MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio 3MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio 4
    (Date:5/23/2013)... said to be the world,s most popular fruit, can ... research with purple GM varieties. , "Working with ... by the addition of a specific compound, allows us ... said Professor Cathie Martin from the John Innes Centre. ... with better flavour, health and shelf life characteristics because ...
    (Date:5/23/2013)... By discovering the new mechanism by which estrogen suppresses ... revealed a potential new approach toward treating certain liver ... and colleagues believe they are changing long-held views in ... issue of the journal Science Signaling . , ... years has been that only receptors located in the ...
    (Date:5/23/2013)... (May 23, 2013) A new report from the ... helping pupils engage in at least 60 minutes of ... , No more than half of American youth meet ... vigorous or moderate intensity physical activity daily, according to ... children are in school for nearly half of their ...
    Breaking Biology News(10 mins):The world's favorite fruit only better-tasting and longer-lasting 2UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2Schools should provide students with daily physical activity, IOM recommends 2
    ... at The University of Texas at Austin have devised a ... help people with Parkinson,s disease. The worms are able ... The researchers have received federal funding that could increase that ... is based on the difficulty that these "parkinsonian" C. ...
    ... play a far greater role in the fate of African elephants ... on these largest terrestrial animals, according to a new University of ... week. In some of the best-documented cases to date, the ... one of the last strongholds of forest elephants in the Democratic ...
    ... tundra are growing faster, suggesting that at least some forests ... new study. While forests elsewhere are thinning from wildfires, ... white spruce trees in the far north of Alaska have ... 1950, the study has found. The health of forests globally ...
    Cached Biology News:Parkinsonian worms may hold the key to identifying drugs for Parkinson's disease 2Parkinsonian worms may hold the key to identifying drugs for Parkinson's disease 3More than 50 percent decline in elephants in eastern Congo due to human conflict: UBC research 2Trees on tundra's border are growing faster in a hotter climate 2Trees on tundra's border are growing faster in a hotter climate 3Trees on tundra's border are growing faster in a hotter climate 4
    ... recombinant protein that has been shown to help ... of cDNA by reverse transcription, in vitro RNA ... Safe Inhibitor tightly binds RNases in a 1:1 ... RNases such as RNase A, RNase B, RNase ...
    ... The BIOLASE Core Kit contains ... perform polymerase assays on a ... In addition to dNTPs, the ... our widely used BIOLASE DNA ...
    Chicken Aortic Smooth Muscle Cells (CAOSMC) (>500,000 cells)...
    ... The National Collection of Pathogenic ... authenticated human pathogenic viruses in ... is able to supply the ... from them, to the scientific ...
    Biology Products: